Ulcerative colitis

Abstract

Ulcerative colitis is a form of inflammatory bowel disease. It is a chronic relapsing condition affecting the colon and rectum and can cause a variety of symptoms, the commonest of which is bloody diarrhoea. Prompt diagnosis, as well as flare identification and management by primary care clinicians can improve patient outcomes such as disease progression and effects on quality of life.

Get full access to this article

View all access options for this article.

References

Bannaga

Selinger

(2015) Inflammatory bowel disease and anxiety: Links, risks, and challenges faced. Clinical and Experimental Gastroenterology 8: 111–117. DOI: 10.2147/CEG.S57982.

Faculty of Sexual and Reproductive Health (2016) Guideline sexual and reproductive health for individuals with inflammatory bowel disease. Available at: www.fsrh.org/news/updated-clinical-guideline-published-srh-for-individuals-with (accessed 8 February 2019).

Frolkis

Dykeman

Negron

, et al. (2013) Risk of surgery for inflammatory bowel diseases has decreased over time: A systematic review and meta-analysis of population-based studies. Gastroenterology 145(5): 996–1006. DOI: 10.1053/j.gastro.2013.07.041.

Goodhand

Wahed

Mawdsley

, et al. (2012) Mood disorders in inflammatory bowel disease: Relation to diagnosis, disease activity, perceived stress, and other factors. Inflammatory Bowel Disease 18(12): 2301–2309. DOI: 10.1002/ibd.22916.

Halfvarson

Bodin

Tysk

, et al. (2003) Inflammatory bowel disease in a Swedish twin cohort: A long-term follow-up of concordance and clinical characteristics. Gastroenterology 124(7): 1767–1773. DOI: 10.1016/S0016-5085(03)00385-8.

Kane

Huo

Aikens

, et al. (2003) Medication non-adherence and the outcomes of patients with quiescent ulcerative colitis. The American Journal of Medicine 114(1): 39–43. DOI: 10.1016/S0002-9343(02)01383-9.

Karvellas

Fedorak

Hanson

, et al. (2007) Increased incidence of colorectal cancer in ulcerative colitis patients diagnosed after 40 years of age. Canadian Journal of Gastroenterology 21(7): 443–446. Available at: www.ncbi.nlm.nih.gov/pmc/articles/PMC2657965/ 9 (accessed 17 May 2019).

Lakatos

(2008) Risk for colorectal cancer in ulcerative colitis: Changes, causes and management strategies. World Journal of Gastroenterology 14(25): 3937–3947. DOI: 10.3748/wjg.14.3937.

Langholz

Munkholm

Davidsen

, et al. (1992) Colorectal cancer risk and mortality in patients with ulcerative colitis. Gastroenterology 103(5): 1444–1451. Available at: www.gastrojournal.org/article/0016-5085(92)91163-X/pdf?referrer= (accessed 8 February 2019)https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2F.

10.

Mowat C, Cole A, Windsor A, et al. (2010) Guidelines for the management of inflammatory bowel disease in adults. Available at: www.bsg.org.uk/resource/guidelines-for-the-management-of-inflammatory-bowel-disease-in-adults.html (accessed 8 February 2019).

11.

Shi

Hamidi

, et al. (2017) Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: A systematic review of population-based studies. The Lancet 360(10114): 2769–2778. DOI: 10.1016/S0140-6736(17)32448-0.

12.

NICE (2015) Clinical knowledge summary: Ulcerative colitis. Available at: https://cks.nice.org.uk/ulcerative-colitis (accessed 8 February 2019).

13.

NICE (2016) Clinical knowledge summary: Osteoporosis - prevention of fragility fractures. Available at: https://cks.nice.org.uk/osteoporosis-prevention-of-fragility-fractures (accessed 17 May 2019).

14.

Piodi

Poloni

Ulivieri

(2014) Managing osteoporosis in ulcerative colitis: Something new? World Journal of Gastroenterology 20(39): 14087–14098. DOI: 10.3748/wjg.v20.i39.14087.

15.

RCGP. Inflammatory bowel disease toolkit. Available at: www.rcgp.org.uk/clinical-and-research/resources/toolkits/inflammatory-bowel-disease-toolkit.aspx (accessed 8 February 2019).

16.

RCGP. Clinical module 2.01: The GP consultation in practice. Available at: www.rcgp.org.uk/training-exams/training/gp-curriculum-overview/online-curriculum/knowing-yourself-and-relating-to-others/2-01-the-gp-consultation-in-practice.aspx (accessed 8 February 2019).

17.

RCGP. Clinical module 3.03: Care of acutely ill people. Available at www.rcgp.org.uk/training-exams/training/gp-curriculum-overview/online-curriculum/applying-clinical-knowledge-section-1/3-03-acutely-ill-people.aspx (accessed 8 February 2019).

18.

RCGP. Clinical module 3.13: Digestive health. Available at: www.rcgp.org.uk/training-exams/training/gp-curriculum-overview/online-curriculum/applying-clinical-knowledge-section-1/3-13-digestive-health.aspx (accessed 8 February 2019).

19.

Spehlmann

Bergun

Burghardt

, et al. (2008) Epidemiology of inflammatory bowel disease in a German twin cohort: Results of a nationwide study. Inflammatory Bowel Diseases 14(7): 968–976. DOI: 10.1002/ibd.20380.

20.

Turvill

O’Connell

Brooks

(2016) Evaluation of a faecal calprotectin care pathway for the use in primary care. Primary Care Research Development 17(5): 428–436. DOI: 10.1017/S1463423616000049.

21.

Vavricka

Schoepfer

Scharl

, et al. (2015) Extraintestinal manifestations of inflammatory bowel disease. Inflammatory Bowel Disease 21(8): 1982–1992. DOI: 10.1097/MIB.0000000000000392.

22.

Waugh

Cummins

Royle

(2013) Faecal calprotectin testing for differentiating amongst inflammatory and non-inflammatory bowel diseases: Systematic review and economic evaluation. Health Technology Assessment 17(55): 1–211. DOI: 10.3310/hta17550.

23.

van Langenberg

(2015) Mesalazine preparations for the treatment of ulcerative colitis: Are all created equal? World Journal of Gastrointestinal Pharmacology and Therapeutics 6(4): 137–144. DOI: 10.4292/wjgpt.v6.i4.137.

24.

Zhang

Y-Z

Y-Y

(2014) Inflammatory bowel disease: Pathogenesis. World Journal of Gastroenterology 20(1): 91–99. DOI: 10.3748/wjg.v20.i1.91.